AU8736691A - Cyclopeptides, a method of preparing them, and their use as drugs - Google Patents

Cyclopeptides, a method of preparing them, and their use as drugs

Info

Publication number
AU8736691A
AU8736691A AU87366/91A AU8736691A AU8736691A AU 8736691 A AU8736691 A AU 8736691A AU 87366/91 A AU87366/91 A AU 87366/91A AU 8736691 A AU8736691 A AU 8736691A AU 8736691 A AU8736691 A AU 8736691A
Authority
AU
Australia
Prior art keywords
cyclopeptides
drugs
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU87366/91A
Other languages
English (en)
Inventor
Stefan Heinrichs
Rainer Palluk
Gerd Schnorrenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19904032271 external-priority patent/DE4032271A1/de
Priority claimed from DE19904032268 external-priority patent/DE4032268A1/de
Priority claimed from DE19904032269 external-priority patent/DE4032269A1/de
Priority claimed from DE19914117733 external-priority patent/DE4117733A1/de
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Publication of AU8736691A publication Critical patent/AU8736691A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • C07K14/582—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU87366/91A 1990-10-11 1991-10-10 Cyclopeptides, a method of preparing them, and their use as drugs Abandoned AU8736691A (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
DE4032271 1990-10-11
DE19904032271 DE4032271A1 (de) 1990-10-11 1990-10-11 Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE19904032268 DE4032268A1 (de) 1990-10-11 1990-10-11 Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE4032269 1990-10-11
DE4032268 1990-10-11
DE19904032269 DE4032269A1 (de) 1990-10-11 1990-10-11 Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE19914117733 DE4117733A1 (de) 1991-05-30 1991-05-30 Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE4117733 1991-05-30

Publications (1)

Publication Number Publication Date
AU8736691A true AU8736691A (en) 1992-05-20

Family

ID=27435038

Family Applications (1)

Application Number Title Priority Date Filing Date
AU87366/91A Abandoned AU8736691A (en) 1990-10-11 1991-10-10 Cyclopeptides, a method of preparing them, and their use as drugs

Country Status (12)

Country Link
EP (1) EP0552238A1 (de)
JP (1) JPH06501950A (de)
KR (1) KR930702395A (de)
AU (1) AU8736691A (de)
CA (1) CA2089747A1 (de)
CZ (1) CZ61893A3 (de)
FI (1) FI931499A0 (de)
HU (1) HUT63859A (de)
IE (1) IE913582A1 (de)
PL (1) PL168456B1 (de)
SK (1) SK32693A3 (de)
WO (1) WO1992006998A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5665704A (en) * 1993-11-12 1997-09-09 Genentech, Inc. Receptor specific atrial natriuretic peptides
US5846932A (en) * 1993-11-12 1998-12-08 Genentech, Inc. Receptor specific atrial natriuretic peptides
US6525022B1 (en) 1993-11-12 2003-02-25 Genentech, Inc. Receptor specific atrial natriuretic peptides
WO1999067286A2 (en) * 1998-06-24 1999-12-29 The Rockefeller University Novel staphylococcus peptides for bacterial interference
US6337385B1 (en) 1998-06-24 2002-01-08 The Rockefeller University Staphylococcus peptides for bacterial interference
FR2797689B1 (fr) * 1999-08-16 2003-06-27 Pasteur Sanofi Diagnostics Utilisation de composes synthetiques pour des immunodosages
US6455587B1 (en) * 2000-03-15 2002-09-24 Pharmacor Inc. Amino acid derivatives as HIV aspartyl protease inhibitors
US7388008B2 (en) 2004-08-02 2008-06-17 Ambrilia Biopharma Inc. Lysine based compounds
AU2006319716B2 (en) 2005-11-30 2012-02-02 Taimed Biologics, Inc. Lysine-based prodrugs of aspartyl protease inhibitors and processes for their preparation
DK2001518T3 (da) 2006-03-30 2013-10-07 Palatin Technologies Inc Cykliske natriuretiske peptidfremstillinger
US8580746B2 (en) 2006-03-30 2013-11-12 Palatin Technologies, Inc. Amide linkage cyclic natriuretic peptide constructs
US7795221B2 (en) 2006-03-30 2010-09-14 Palatin Technologies, Inc. Linear natriuretic peptide constructs
JP5401652B2 (ja) 2006-09-21 2014-01-29 タイメッド バイオロジクス インコーポレイテッド プロテアーゼ阻害剤
PT2118123E (pt) 2007-01-31 2016-02-10 Harvard College Péptidos de p53 estabilizados e suas utilizações
WO2008121767A2 (en) 2007-03-28 2008-10-09 President And Fellows Of Harvard College Stitched polypeptides
RU2582678C2 (ru) 2010-08-13 2016-04-27 Эйлерон Терапьютикс, Инк. Пептидомиметические макроциклы
TWI643868B (zh) 2011-10-18 2018-12-11 艾利倫治療公司 擬肽巨環化合物
JP6450191B2 (ja) 2012-02-15 2019-01-09 エイルロン セラピューティクス，インコーポレイテッド ペプチドミメティック大環状化合物
EP2819688A4 (de) 2012-02-15 2015-10-28 Aileron Therapeutics Inc Triazol- und thioethervernetzte peptidomimetische makrozyklen
WO2014071241A1 (en) 2012-11-01 2014-05-08 Aileron Therapeutics, Inc. Disubstituted amino acids and methods of preparation and use thereof
WO2015179438A1 (en) * 2014-05-20 2015-11-26 Ohio State Innovation Foundation Small molecule rac or rho inhibitors
KR102570210B1 (ko) 2014-09-24 2023-08-23 에일러론 테라퓨틱스 인코포레이티드 펩티드모방 거대고리 및 이의 제제
KR20170058424A (ko) 2014-09-24 2017-05-26 에일러론 테라퓨틱스 인코포레이티드 펩티드모방 거대고리 및 이의 용도
JP2018516844A (ja) 2015-03-20 2018-06-28 エルロン・セラピューティクス・インコーポレイテッドＡｉｌｅｒｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． ペプチド模倣大環状分子およびその使用
US10023613B2 (en) 2015-09-10 2018-07-17 Aileron Therapeutics, Inc. Peptidomimetic macrocycles as modulators of MCL-1

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337891C (en) * 1987-12-16 1996-01-02 John Dimaio Anf derivatives with novel bridging
US4935492A (en) * 1987-12-24 1990-06-19 California Biotechnology Inc. Cyclic analogs of atrial natriuretic peptides
DK380288D0 (da) * 1988-07-07 1988-07-07 Novo Industri As Hidtil ukendet peptider

Also Published As

Publication number Publication date
HUT63859A (en) 1993-10-28
WO1992006998A1 (de) 1992-04-30
FI931499A (fi) 1993-04-02
HU9301054D0 (en) 1993-07-28
PL168456B1 (pl) 1996-02-29
KR930702395A (ko) 1993-09-09
JPH06501950A (ja) 1994-03-03
CZ61893A3 (en) 1994-01-19
SK32693A3 (en) 1993-09-09
EP0552238A1 (de) 1993-07-28
CA2089747A1 (en) 1992-04-12
FI931499A0 (fi) 1993-04-02
IE913582A1 (en) 1992-04-22

Similar Documents

Publication Publication Date Title
AU8736691A (en) Cyclopeptides, a method of preparing them, and their use as drugs
CS189391A3 (en) Dialkoxypiridylbenzimidazole derivatives, process of their preparation and their pharmaceutical use
EP0412350A3 (en) Renininhibitors, procedure for their preparation and use as medicaments
LTIP1713A (en) Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use
AU623766B2 (en) N-heteroaryl-4-quinolinamines, a process for their preparation and their use as medicaments
AU5703390A (en) Sucralfate and a medicament and methods for preparing same
CS331491A3 (en) Cyclopeptides, process of their preparation and pharmaceuticals based thereon
AU650261B2 (en) Derivatives of glycinamide, their preparation and medicaments containing them
AU1245495A (en) Novel 2-arylalkenyl-azacycloalkane derivatives as sigma receptor ligands, preparation method therefor and therapeutical use thereof
AU622007B2 (en) Derivatives of thieno-triazolo-diazepine, a preparation process of the same and therapeutic compositions
AU2653788A (en) Manumycin derivatives, a process for the preparation thereof, and the use thereof
AU7257891A (en) New benzimidazole derivatives, method for preparing them and their pharmaceutical use
AU7498791A (en) New leucotriene b4 derivatives, methods of preparing them and their use as drugs
AU7143887A (en) Benzimidazolesulfonamides and imidazopyridine-sulfonamides, their preparation and their application as drugs
AU1314995A (en) Aminosulphonyl-phenyl-1h-pyrrole derivatives, method of their preparation and their use
AU2836689A (en) Pyrazol- and indazolpyridin amines, a process for their preparation and their use as medicaments
AU7260091A (en) Insulin derivatives, a process for their preparation, and their use
AU6118090A (en) N,n'-bis-1,3,5-triazin-6-ylpiperazines, and process for their preparation
AU2992189A (en) Method of preparing 4,4'-methylenedianiline
AU609980B2 (en) Hydrazinocarbonyloxylabdanes, a process for their preparation and their use as medicaments
AU4266089A (en) 3-aryloxymethyl-cephalosporin derivatives, their preparation and their medical use
AU630725B2 (en) 2-amino-7-carbamoyl-1,2,3,4-tetrahydronaphthalenes, process for preparing them and their use as drugs
AU2409292A (en) New leukotriene-b4 antagonists, methods of preparing them and their use as drugs
EP0477717A3 (en) New 3-substituted cephalosporins, process for their preparation and their use as medicinal preparations
AU6623690A (en) Novel sulfamide derivatives, a method for obtaining them and their use as a drug